Chronic bacterial infection is one of the key challenges in caring for patients with cystic fibrosis (CF ... including resistance by Pseudomonas aeruginosa due to electrolyte interference ...

Pseudomonas aeruginosa, Escherichia coli, Burkholderia cepacia or Klebsiella pneumonia. To evaluate the progression of cystic fibrosis, a pulmonary function test is important. Spirometry is a type ...

Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy ® for applications in early disease detection and precision ...

today announced that the Cystic Fibrosis Foundation has made an up to USD $2.3 million equity investment (circa £1.7 million) in Owlstone to develop a breath test for Pseudomonas aeruginosa (PA ...

Pseudomonas aeruginosa—an environmental bacteria ... People with conditions such as COPD (smoking-related lung damage), cystic fibrosis (CF), and non-CF bronchiectasis are particularly susceptible.

in this little device—really exhibit the properties of cystic fibrosis in many ways,” Ingber said. The CF airway chip is also more susceptible to bacterial infection, similar to patients. To test this ...

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...

Second, we use a model cystic fibrosis lung microbiome to focus on understanding how the evolution of Pseudomonas aeruginosa bacterial pathogen is shaped by sub-inhibitory antibiotic concentrations, ...

The company has two phase 3 development programs underway for the treatment of bronchiolitis obliterans syndrome (BOS) and non-cystic fibrosis ... Chronic Pseudomonas aeruginosa lung infection ...